FPS
MNTA

Fieldpoint Private Securities’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Fieldpoint Private Securities’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-2,423
Closed -$45K – 603
2017
Q3 		$45K Buy
+2,423
New +$40.5K 0.02% 404

Other funds holding MNTA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Fieldpoint Private Securities's MNTA Position: Q4 2017 in Review

Fieldpoint Private Securities sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2017, closing a stake of 2,423 shares — an estimated $45K sold.

Fieldpoint Private Securities first reported a position in MNTA in Q3 2017 and held it in 1 quarter. The position peaked at $45K in Q3 2017. 166 funds tracked by Wall St. Rank hold MNTA as of Q4 2017.

  • Fieldpoint Private Securities reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2017 after selling out during the quarter.
  • Fieldpoint Private Securities sold 2,423 Momenta Pharmaceuticals, Inc. shares in Q4 2017, an estimated $45K.
  • Fieldpoint Private Securities first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2017 and held it in 1 quarter.
  • Fieldpoint Private Securities's Momenta Pharmaceuticals, Inc. position peaked at $45K in Q3 2017.
  • 166 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2017.

Based on Fieldpoint Private Securities's 13F filing for Q4 2017, filed 15 Feb 2018.